ClinicalTrials.govpublic full text
Efficacy and Tolerability of ILY101 in Dialysis Patients With Hyperphosphatemia
kidney diseases, renal insufficiency, hyperphosphatemia, chronic kidney disease, dialysis, hyperphosphatemia in ckd patients on dialysis, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 915884
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.